Date
11 February 2025Location
Online via Webex, 13:00-14:00About the event
Consultant pharmacist Lelly Oboh outlined the importance of personalising evidence-based medicine in patients with polypharmacy, explaining the tools available and illustrating how to use these resources effectively to deprescribe inappropriate medicines to get outcomes that matter most to patients.
This is the first of two polypharmacy events. You can find more information about our second webinar here.
Why it’s important
The National Overprescribing review highlighted that 10% of medicines prescribed in primary care may be inappropriate and those taking 10 or more medicines are 300 times more likely to have a drug related hospital admission, highlighting the importance of deprescribing.
In England, 8.4m people are regularly prescribed 5 or more medicines, with 1 in 5 hospital admissions in over-65s caused by the adverse effects of medicines. 1 in 10 people over 65years take 8 or more medicines rising to 1 in 4 in those over 85 years. Polypharmacy is associated with increased adverse drug outcomes, cost and medicines waste
It is critical that clinician training or support to tackle overprescribing, encourages and facilitates shared decision-making, the importance of listening to patients, cultural competency, deprescribing, identifying adverse drug events and instances where harm outweighs benefits.
What was covered
- The patient-centred approach to tackle problematic polypharmacy
- The importance of the conversation with the patient/carer and shared decision making
- Resources, tools and guidance to use when undertaking patient-centred structured medication reviews and deprescribing
Speakers
Learn more about the SPS team who are running this event.
Resources
Information presented in these resources is correct at time of recording. Current guidance should be followed.
Webinar recording
You can watch a recording of the webinar below.
Presentation slides
Slides from the webinar can be viewed below.
Contact us
Please contact the Admin Team if you have any questions.